Heart Arrhythmias: Symptoms, Causes, Diagnosis, and Treatment (Complete Guide)

Heart arrhythmias are among the most common cardiac conditions in modern medicine, and also among the most varied. The category encompasses everything from benign isolated extra beats that nearly everyone experiences to life-threatening rhythms that can cause sudden cardiac death. Some arrhythmias produce striking symptoms that bring patients to medical attention immediately. Others develop silently over years, identified only through routine examination or after a serious complication has occurred. Understanding heart arrhythmias requires recognizing both their diversity and their underlying unity. All arrhythmias represent disruptions of the heart's normal electrical activity, but the specific disruptions involved vary substantially. Some originate from the upper chambers, others from the lower. Some produce rapid rates, others abnormally slow ones. Some result from underlying heart disease, others from genetic conditions, metabolic disturbances, or external triggers. The clinical importance of arrhythmias extends well beyond symptoms. Atrial fibrillation, the most common sustained arrhythmia, is one of the leading preventable causes of stroke worldwide. Ventricular arrhythmias account for many cases of sudden cardiac death. Heart block can produce dangerous slowing that requires permanent pacing. The opportunity to prevent serious cardiovascular events through appropriate diagnosis and treatment of arrhythmias is one of the most consequential in modern medicine. This guide explains the main categories of heart arrhythmias, what causes them, how they are recognized and diagnosed, and how modern treatment has transformed outcomes for patients across the spectrum of rhythm disorders. For a focused look at the most clinically important arrhythmia, see Atrial Fibrillation (AFib): Symptoms, Causes, Stroke Risk, Diagnosis, and Advanced Treatment.

What Heart Arrhythmias Actually Are

A heart arrhythmia is any deviation from the normal electrical rhythm of the heart. To understand what this means, it helps to begin with how the heart's electrical system normally works. The heart's contractions are coordinated by a precisely timed sequence of electrical events. A small cluster of specialized cells in the right atrium called the sinoatrial node generates electrical impulses at a rate adjusted continuously to the body's needs, faster during exertion or stress and slower during rest. Each impulse spreads across the atria, triggering them to contract. The signal then passes through the atrioventricular node, which briefly delays it to allow ventricular filling, before traveling through specialized conduction tissue to trigger ventricular contraction. The result of this orchestrated process, repeated 60 to 100 times per minute at rest, is a regular and coordinated heartbeat. The atria contract first, the ventricles a fraction of a second later, and blood moves through the heart efficiently. Arrhythmias arise when something disrupts this sequence. The disruption can take many forms. The signal may originate from an unusual location, producing an early beat. It may follow an abnormal pathway, creating reentrant circuits that produce rapid rhythms. The atria may fail to maintain organized electrical activity altogether. The conduction system may slow or block, producing pauses or dropped beats. Each pattern represents a different mechanism with different clinical implications.

The Main Categories of Arrhythmias

Heart arrhythmias are typically classified by where they originate and by whether they produce rates that are too fast or too slow.

Tachyarrhythmias

Tachyarrhythmias are rhythms that produce heart rates faster than normal, generally above 100 beats per minute. They are subdivided based on the location of origin. Supraventricular tachyarrhythmias originate above the ventricles, in the atria or in tissue near the atrioventricular node. They include sinus tachycardia, atrial fibrillation, atrial flutter, and various forms of supraventricular tachycardia. Most supraventricular arrhythmias are not immediately life-threatening, though they can produce significant symptoms and, in the case of atrial fibrillation, substantial long-term risk. Ventricular tachyarrhythmias originate from within the ventricles. They include ventricular tachycardia and ventricular fibrillation. Ventricular arrhythmias are typically more concerning than supraventricular forms, particularly in the setting of underlying heart disease, and can degenerate into rhythms incompatible with effective circulation. For a deeper look at specific rapid rhythms, see Tachycardia: Causes, Symptoms, and Treatment Options.

Bradyarrhythmias

Bradyarrhythmias produce heart rates slower than normal, generally below 60 beats per minute. Some slow rates are physiological, particularly in athletes whose hearts have adapted to efficient pumping. Pathological bradyarrhythmias result from disorders of the heart's natural pacemakers or its conduction system. Sinus bradycardia, sometimes called sinus node dysfunction or sick sinus syndrome, results from inadequate function of the sinoatrial node. Heart block, which occurs at the atrioventricular node or below, produces delays or interruptions in conduction from the atria to the ventricles. When bradyarrhythmias produce symptoms, including fatigue, dizziness, or fainting, treatment with a permanent pacemaker is typically indicated.

Premature Beats

Premature beats are individual heartbeats that occur earlier than expected, originating from a location other than the sinoatrial node. They can be premature atrial beats, originating from the atria, or premature ventricular beats, originating from the ventricles. Premature beats are extremely common, occurring in nearly everyone at some point, and are usually entirely benign in people without underlying heart disease. For more on the experience of premature beats, see Heart Palpitations: Causes, Symptoms, and When to Worry.

Atrial Fibrillation

Atrial fibrillation deserves separate emphasis as the most common sustained arrhythmia and the one with the greatest public health impact. In atrial fibrillation, the atria do not contract in coordinated fashion. Chaotic electrical activity replaces the organized rhythm, producing an irregularly irregular rapid heart rate. The condition is associated with substantial stroke risk and warrants both rhythm management and stroke prevention through anticoagulation. For a focused overview of irregular rhythms, see Irregular Heartbeat: Causes, Symptoms, and Treatment Options.

Specific Arrhythmias of Clinical Importance

Within the broad categories, several specific arrhythmias deserve more detailed attention.

Atrial Fibrillation

Atrial fibrillation is the most common sustained cardiac arrhythmia. It affects approximately 10 percent of people by age 80, and its prevalence continues to rise as populations age. The condition produces an irregularly irregular rapid heart rate, often accompanied by palpitations, fatigue, shortness of breath, and reduced exercise tolerance, though some patients have no symptoms at all. The clinical importance of atrial fibrillation comes primarily from its association with stroke. Patients with atrial fibrillation have an elevated risk of clot formation in the heart, particularly in the left atrial appendage, and these clots can travel to the brain and cause stroke. Strokes from atrial fibrillation tend to be more severe than other types, making prevention through anticoagulation a central component of care. Treatment involves both stroke prevention through anticoagulation and rhythm management through medications, catheter ablation, or both. The choice among approaches depends on multiple factors and is increasingly individualized. For more on treatment options, see AFib Treatment Options: Medications vs Ablation (What Works Best?).

Atrial Flutter

Atrial flutter is a related but distinct condition in which the atria contract rapidly in a more organized pattern than in atrial fibrillation. The result is typically a fast but more regular rhythm. Atrial flutter shares many characteristics with atrial fibrillation, including stroke risk, and is often managed with similar approaches. Catheter ablation for atrial flutter has particularly high success rates, often exceeding 90 percent.

Supraventricular Tachycardia

Supraventricular tachycardia, often shortened to SVT, refers to episodes of rapid heart rate that begin and end suddenly, typically with rates between 150 and 250 beats per minute. Several specific subtypes exist. Atrioventricular nodal reentrant tachycardia, abbreviated as AVNRT, is the most common form, particularly in younger women. Atrioventricular reentrant tachycardia, abbreviated as AVRT, involves an extra electrical pathway connecting the atria and ventricles. Atrial tachycardia originates from a focal source in the atrium. Most forms of SVT are not life-threatening but can produce significant symptoms. Catheter ablation is highly effective for most subtypes, often providing definitive cure with success rates above 95 percent.

Ventricular Tachycardia

Ventricular tachycardia originates from the ventricles and is typically more concerning than supraventricular arrhythmias. Sustained ventricular tachycardia, lasting more than 30 seconds or producing significant symptoms, is a medical emergency. The risk of degeneration into ventricular fibrillation, and consequent cardiac arrest, makes prompt evaluation essential. Ventricular tachycardia frequently occurs in the setting of structural heart disease, particularly after a heart attack or in cardiomyopathy. It can also arise from inherited electrical conditions, including long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. Patients with sustained ventricular tachycardia generally require specialized long-term management, including consideration of an implantable cardioverter-defibrillator.

Ventricular Fibrillation

Ventricular fibrillation is the most dangerous of the rapid ventricular rhythms. The ventricles quiver chaotically rather than contracting effectively, and circulation essentially stops. Ventricular fibrillation is the typical rhythm of cardiac arrest and requires immediate defibrillation. Without rapid treatment, it is fatal within minutes.

Heart Block

Heart block refers to disorders of conduction at the atrioventricular node or below. First-degree block produces a delay in conduction but does not typically cause symptoms. Second-degree block produces intermittent failures of conduction, leading to occasional dropped beats. Third-degree block, also called complete heart block, produces complete failure of atrial impulses to reach the ventricles. Significant heart block, particularly third-degree, can produce fatigue, dizziness, fainting, and in some cases sudden cardiac arrest. Treatment for symptomatic heart block typically involves implantation of a permanent pacemaker.

Sick Sinus Syndrome

Sick sinus syndrome refers to a group of conditions in which the sinoatrial node functions abnormally. Patients may experience inappropriate slow rhythms, pauses, or alternating slow and fast rhythms. The condition is most common in older patients and often presents with fatigue, dizziness, or fainting. Pacemaker implantation is the typical treatment when symptoms are significant.

Symptoms

The symptoms of arrhythmias vary based on the type, the rate, the duration, and the presence of underlying heart disease. The most common symptom is the awareness of the abnormal rhythm itself, often described as palpitations, fluttering, pounding, or skipped beats. Some patients are acutely aware of every irregularity. Others perceive only sustained or particularly fast rhythms. Lightheadedness or dizziness can accompany arrhythmias, particularly when the rate is very fast or very slow, or when the rhythm reduces effective cardiac output. Some patients experience near-fainting or actual loss of consciousness during episodes, which is a particular concern and warrants prompt evaluation. Shortness of breath is common during sustained arrhythmias, especially during physical activity or in patients with underlying heart disease. Reduced exercise tolerance can be an early sign. Chest discomfort, often described as pressure or tightness, can occur during episodes, particularly in patients with coronary artery disease. Fatigue and weakness, sometimes lasting hours after an episode, are reported by many patients. Some patients have no symptoms at all. The arrhythmia is detected incidentally, often through routine examination, wearable devices, or evaluation for another reason. The absence of symptoms does not necessarily mean the arrhythmia is benign, particularly in the case of atrial fibrillation, where stroke risk is present regardless of symptom severity.

Common Causes and Risk Factors

Arrhythmias arise from a wide range of causes, often involving multiple contributing factors. Underlying heart disease is one of the major contributors. Coronary artery disease, prior heart attack, heart failure, valve disease, and structural abnormalities all increase the likelihood of various arrhythmias. The damaged cardiac tissue creates substrate that favors abnormal electrical activity. Hypertension contributes to atrial fibrillation through its effects on atrial structure over years. Effective blood pressure control reduces both the development and the severity of this arrhythmia. Obesity and metabolic conditions, including diabetes and metabolic syndrome, contribute to several arrhythmias through their effects on cardiovascular structure and function. Weight loss in overweight patients with atrial fibrillation has been shown to reduce arrhythmia burden substantially. Sleep apnea, when present and untreated, contributes to atrial fibrillation and other arrhythmias through nighttime physiological disruptions that promote arrhythmia development over time. Hyperthyroidism is a classic cause of arrhythmia, particularly atrial fibrillation. Treatment of the underlying thyroid disease often resolves the rhythm disturbance. Excessive alcohol consumption contributes to atrial fibrillation both acutely as a trigger and chronically through structural cardiac effects. The relationship is dose-dependent. Caffeine and various stimulants can trigger arrhythmias in susceptible individuals, though sensitivity varies substantially. Electrolyte disturbances, particularly low potassium and low magnesium, can produce arrhythmias and lower the threshold for irregular beats in patients otherwise stable. Various medications can contribute to arrhythmias as side effects. These include thyroid hormones, certain asthma medications, decongestants, and a range of others. Genetic factors play a role in many arrhythmias. Some, including long QT syndrome and Brugada syndrome, are explicitly inherited conditions. Others, including atrial fibrillation, have polygenic contributions that influence individual susceptibility. For a deeper look at causes specifically in atrial fibrillation, see What Causes Atrial Fibrillation? Mechanisms, Triggers, and Risk Factors Explained.

How Arrhythmias Are Diagnosed

The diagnosis of arrhythmias depends on direct recording of the heart's electrical activity, and modern diagnostic tools have substantially improved the ability to identify even intermittent rhythms.

Electrocardiogram

The standard 12-lead electrocardiogram records the heart's electrical activity over a few seconds and is the foundation of arrhythmia diagnosis. When the patient is in the abnormal rhythm at the time of recording, the ECG can usually identify the specific type and provide essential information about the underlying mechanism. For patients in normal rhythm at the time of an ECG, the recording cannot diagnose intermittent arrhythmias, requiring longer monitoring.

Ambulatory Monitoring

For intermittent rhythms, ambulatory monitoring extends the period of recording. Holter monitors record continuously for 24 to 48 hours. Patch monitors and event monitors extend recording to weeks. Implantable loop recorders allow monitoring for years in patients with very infrequent episodes. The choice of monitoring depends on the frequency of suspected episodes and the strength of clinical suspicion. For more on diagnostic tools specifically in atrial fibrillation, see AFib Diagnosis: ECG, Holter Monitoring, and Advanced Testing Explained.

Wearable Devices

Consumer wearable devices, including smartwatches, have become useful tools in arrhythmia detection. Many can identify irregular rhythms and produce single-lead ECG recordings during episodes. While not fully diagnostic, the data often expedites formal medical evaluation.

Echocardiography

Echocardiography evaluates the structure and function of the heart, identifying underlying conditions that may contribute to arrhythmias. It is a routine part of arrhythmia evaluation in most cases.

Laboratory Testing

Blood tests typically include thyroid function, electrolytes, kidney function, and complete blood count. These can identify systemic contributors including hyperthyroidism, anemia, electrolyte abnormalities, and dehydration.

Stress Testing

Exercise stress testing can identify exercise-induced arrhythmias and evaluate the heart's response to exertion.

Electrophysiology Studies

For complex arrhythmias, electrophysiology studies provide detailed mapping of the heart's electrical activity. Catheters advanced into the heart through veins assess the conduction system directly. These studies are typically performed at specialized centers and are often combined with catheter ablation when an abnormal pathway is identified.

Treatment Approaches

Treatment of arrhythmias depends fundamentally on the type, the underlying cause, the symptoms, and the patient's overall cardiac context.

Lifestyle Modification

For many arrhythmias, addressing modifiable factors substantially reduces frequency and severity. Weight management, treatment of sleep apnea, alcohol moderation, blood pressure control, and management of cardiovascular risk factors all contribute to rhythm stability. For more on lifestyle factors, see Lifestyle Changes That Improve Atrial Fibrillation: What Actually Works?.

Treating Underlying Causes

For arrhythmias secondary to other conditions, addressing the underlying cause often resolves the rhythm disturbance. Treating hyperthyroidism, correcting electrolyte abnormalities, addressing significant anemia, or modifying offending medications can all be definitive treatments.

Medications

Several medication classes are used in arrhythmia management. Beta blockers and calcium channel blockers slow the heart rate and reduce the frequency of various arrhythmias. They are widely used both as primary therapy and in combination with other approaches. Antiarrhythmic medications, including amiodarone, flecainide, propafenone, sotalol, and others, work directly on the cardiac electrical system. Each has specific indications, contraindications, and side effect profiles, and selection depends on the rhythm and patient factors. Anticoagulants are used in specific arrhythmias, particularly atrial fibrillation and atrial flutter, to prevent stroke. The decision to anticoagulate is independent of decisions about rhythm management. For more on anticoagulants, see Blood Thinners: Benefits, Risks, and Who Needs Them.

Cardioversion

Electrical cardioversion delivers a controlled shock to the chest under brief sedation, restoring normal rhythm in patients with sustained atrial fibrillation, atrial flutter, or hemodynamically unstable tachycardias.

Catheter Ablation

Catheter ablation has become a definitive treatment for many forms of arrhythmia. The procedure uses thin catheters advanced through veins to deliver energy to small areas of cardiac tissue responsible for initiating or sustaining the abnormal rhythm. Modern ablation can address many forms of supraventricular tachycardia, atrial fibrillation, atrial flutter, and certain ventricular tachycardias with high success rates. The introduction of pulsed field ablation, a newer technology that selectively damages cardiac tissue while sparing surrounding structures, has been one of the most important recent developments in this area. For more on catheter ablation, see Catheter Ablation for AFib: Success Rates, Risks, and What to Expect.

Pacemakers

Permanent pacemakers are used for patients with bradyarrhythmias, including significant heart block and sick sinus syndrome. The device monitors the heart's rhythm and provides electrical stimulation when the heart's intrinsic rate is too slow or absent. Modern pacemakers are sophisticated devices that can adjust the heart rate based on activity level.

Implantable Cardioverter-Defibrillators

Patients at risk for life-threatening ventricular arrhythmias may receive an implantable cardioverter-defibrillator. The device monitors the rhythm continuously and delivers a defibrillating shock if a dangerous rhythm is detected. These devices have substantially reduced sudden cardiac death in high-risk patients.

When Arrhythmias Are Dangerous

Most arrhythmias are not immediately life-threatening, but several patterns warrant urgent attention. Arrhythmia accompanied by chest pain or pressure suggests possible inadequate cardiac perfusion and warrants emergency evaluation, particularly in patients with coronary artery disease. Severe shortness of breath during an arrhythmia suggests that the heart is not maintaining adequate output, which can occur during fast or poorly tolerated rhythms. Lightheadedness, near-fainting, or actual loss of consciousness during an arrhythmia warrants prompt evaluation. Loss of consciousness indicates that cardiac output dropped below the threshold needed to maintain cerebral perfusion. Sustained ventricular tachycardia, particularly in patients with structural heart disease, is a medical emergency. Ventricular fibrillation is the rhythm of cardiac arrest and requires immediate defibrillation. Any new neurological symptoms during or after an arrhythmia, particularly in patients with atrial fibrillation, may indicate stroke and require immediate emergency evaluation. For more on stroke recognition, see Stroke Symptoms: Early Signs You Should Never Ignore.

Special Patient Groups

Older Patients

Older patients have higher rates of most arrhythmias, particularly atrial fibrillation. Treatment considerations often differ from those in younger patients, with greater attention to bleeding risk on anticoagulation, frailty, and overall life expectancy. Most arrhythmias are still treatable in older patients, though the balance of risks and benefits requires individualized assessment.

Younger Patients

Arrhythmias in younger patients warrant particular attention to inherited conditions. Long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy can all present with arrhythmias and have implications for both treatment and family screening. Younger patients with significant arrhythmias often benefit from comprehensive evaluation including consideration of genetic testing.

Athletes

Endurance athletes have somewhat elevated rates of certain arrhythmias, particularly atrial fibrillation. The relationship between extreme endurance exercise and arrhythmia is real but not fully understood. Management often involves discussion of training patterns alongside conventional treatment.

Patients with Heart Failure

Patients with heart failure are at elevated risk for several arrhythmias, including atrial fibrillation and ventricular arrhythmias. Management is often more complex, with closer attention to medication choices and consideration of devices including implantable defibrillators.

Pregnancy

Arrhythmias during pregnancy require specific considerations. Some medications used for arrhythmia management are not safe in pregnancy, and the choice of treatment must balance maternal and fetal considerations. Many pregnancy-related arrhythmias resolve after delivery.

Prevention

The prevention of arrhythmias is closely tied to the broader prevention of cardiovascular disease. Several interventions reduce the development and progression of various arrhythmias. Maintaining a healthy weight reduces the development of atrial fibrillation and other arrhythmias. Managing blood pressure aggressively reduces atrial remodeling and the development of atrial fibrillation. Treating diabetes effectively reduces multiple pathways to arrhythmia development. Treating sleep apnea, when present, reduces arrhythmia frequency and severity. Limiting alcohol consumption reduces atrial fibrillation development and triggering of episodes. Avoiding tobacco reduces broader cardiovascular damage that contributes to arrhythmias. Maintaining regular moderate physical activity supports cardiovascular health overall. Managing stress and ensuring adequate sleep contribute to autonomic stability. These same interventions also reduce arrhythmia frequency and severity in patients who already have them, which is why comprehensive cardiovascular care is so important in arrhythmia management. For more on arrhythmia connections to alcohol specifically, see AFib and Alcohol: What You Need to Know.

When to See a Specialist

Many patients with arrhythmias are appropriately managed by their primary care physician and a general cardiologist. Specialist referral to an electrophysiologist, a cardiologist with additional training in heart rhythm disorders, becomes valuable in specific situations. These include unusual or complex arrhythmias, symptomatic rhythms despite initial treatment, consideration of catheter ablation, evaluation for pacemakers or implantable defibrillators, suspected inherited arrhythmia syndromes, and any situation in which the standard approach is producing unsatisfactory outcomes. Specialized arrhythmia centers offer access to advanced diagnostic technologies and the full range of treatment options, including the newer ablation technologies.

Conclusion

Heart arrhythmias represent a broad and clinically diverse category of conditions, ranging from completely benign to immediately life-threatening. The category includes the most common sustained arrhythmia, atrial fibrillation, with its substantial public health impact through stroke risk. It includes the dangerous ventricular arrhythmias responsible for many cases of sudden cardiac death. It includes a range of more benign rhythms that nonetheless produce symptoms requiring evaluation. The modern toolkit for arrhythmia management is broad and increasingly effective. Diagnostic capabilities have expanded substantially, with extended monitoring tools and consumer wearable devices enabling earlier detection. Therapeutic options have grown across all categories, with newer ablation technologies, improved medications, refined device therapy, and better integration of lifestyle interventions all contributing to better outcomes. For patients experiencing symptoms that might suggest an arrhythmia, evaluation is straightforward when symptoms warrant it. Most arrhythmias are not dangerous, but recognizing patterns that suggest something more serious and seeking evaluation when those patterns appear allows the rhythms warranting treatment to be identified and managed effectively. For patients diagnosed with an arrhythmia, the treatment approach depends fundamentally on the type, the underlying contributors, and the specific clinical context. The combination of medical treatment, procedural intervention when appropriate, and consistent attention to modifiable factors typically produces the best long-term outcomes. The trajectory of most arrhythmias is not fixed, and engaged management can substantially influence the course of the condition over time. The progress in this field over recent decades, with its consistent improvements in both safety and effectiveness across the spectrum of rhythm disorders, illustrates how cardiac care continues to evolve. For patients today facing any of the arrhythmias discussed in this guide, the available options are broader, more individualized, and more effective than at any previous point in cardiac history.